Friday May 9, 01:49 PM
Adolor says FDA delays issue of action letter on Entereg
NEW YORK (Thomson Financial) - Adolor Corp (NASDAQ: ADLR - news) . Friday said the Food and Drug Administration has told the company that it will not be issuing an action letter on the company's new drug application for opioid pain reliever Entereg by May 10.
The FDA didn't provide a specific date, but informed the company that it expects to issue the action letter shortly.
Adolor shares closed at $4.80 Thursday.
Christie Rizk
cr/vj
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
NNNN
|
|
|
Send Article by Email
Send Article by IM
Blog This with Y! 360
Printable View
